The suppression of YAP/TAZ activity in in vivo studies of breast cancer, pancreatic cancer, and osteosarcoma have also demonstrated the contribution of these downstream Hippo proteins on tumorigenesis (51, 54, 55). Here, YAP1 is linked to breast carcinoma.